Objective
Vasomotor symptoms (VMS, i.e. hot flashes or night sweats) are reported by many, but not all, women. The extent to which VMS are genetically determined is unknown. We evaluated the relationship of genetic variation and VMS.
Methods
In this observational study, we accessed data from three genome-wide association studies (GWAS)(SHARe, WHIMS+, GARNET studies, total n= 17,695) of European American (EA), African American (AA), and Hispanic American (HA) postmenopausal women aged 50-79 years at baseline in the Women’s Health Initiative Study. We examined genetic variation in relation to VMS (yes/no) in each study and using trans-ethnic inverse variance fixed-effects meta-analysis.11,078,977 single-nucleotide polymorphisms (SNPs) met the quality criteria.
Results
After adjustment for covariates and population structure 3 SNPs (on chromosomes 3 and 11) were associated with VMS at the genome-wide threshold of 5 × 10-8 in the AA SHARE GWAS but were not associated in the other cohorts. However, in the meta-analysis, 14 SNPs, all located on chromosome 4 in the tachykinin receptor 3 (TACR3) locus, had p-values of <5×10-8. These SNPs’ effect sizes were similar across studies/participants’ ancestry (OR~1.5).
Conclusions
Genetic variation in TACR3 may contribute to the risk of VMS. To our knowledge, this is the first GWAS to examine SNPs associated with VMS. These results support the biological hypothesis of a role for TACR3 in VMS, which was previously hypothesized from animal and human studies. Further study of these variants may lead to new insights into the biological pathways involved in VMS, which are poorly understood.